Navigation Links
Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
Date:8/27/2007

TORONTO, Aug. 27 /PRNewswire/ -- Drug Royalty LP 2 (DRC) announced today the purchase of 25% of Enzon Pharmaceuticals, Inc.'s (ENZN) worldwide royalty interest in PEG-INTRON for $92.5M. DRC will also provide a $15M milestone payment in 2012 should certain royalty recognition levels be met. PEG-INTRON (peginterferon alpha-2b), is approved for the treatment of Hepatitis C and is marketed worldwide by Schering-Plough Corporation (SGP).

Speaking on behalf of DRC, Paul Kirkconnell, Managing Director, said: "DRC is very pleased to be working with Enzon Pharmaceuticals. We believe that PEG- INTRON is one of the most advanced medications to treat Hepatitis C on the market today." Kirkconnell added, "With access to significant capital and a long track record in completing royalty transactions, we take pride in meeting the needs of pharmaceutical companies such as Enzon."

About PEG-INTRON(R)

PEG-INTRON is a PEG-enhanced version of Schering-Plough's alpha interferon product, INTRON(R) A, which is used both as a monotherapy and in combination with REBETOL(R) (ribavirin) capsules for the treatment of chronic hepatitis C. Under Enzon's license agreement with Schering-Plough, Schering-Plough holds an exclusive worldwide license to PEG-INTRON, and Enzon receives royalties on worldwide sales of PEG-INTRON. Schering-Plough is responsible for all manufacturing, marketing, and development activities for PEG-INTRON. Enzon designed PEG-INTRON to allow for less frequent dosing and to yield greater efficacy, as compared to INTRON A. PEG-INTRON is marketed worldwide by Schering-Plough and its affiliates.

About Drug Royalty Corporation, Inc. (DRC)

Drug Royalty Corporation ("DRC") is a privately held investment management company, focused on the healthcare industry, with over $1 billion under management. DRC currently manages two funds: the Royalty Monetization Fund and the Structured Finance Fund.

Its Royalty Monetization Fund acquires existing roya
'/>"/>

SOURCE Drug Royalty Corporation, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. Speaker announces business members of IT Task Force
11. Doyle announces technology tax credits for Berbee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2015)... 24, 2015 , Adds integrated ... Expands product offering for chronic kidney disease and oncology ... diabetes-related complications and dermatology , Increases group revenue ... or ,the Company"), a leading China ... marketing biopharmaceutical products, today announced that it has acquired ...
(Date:7/23/2015)... -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced ... quarter 2015 on Thursday, August 6, 2015. The Company also ... day at 5:00 pm ET to discuss the second quarter ... will be hosted by Andrew Gengos , President and ... LIVE CALL: , , ,  (877) 853-5636 (toll-free); international ...
(Date:7/23/2015)... ... July 23, 2015 , ... Science and technology continue to improve all ... and devices – according to Susan Chang, MD, director of the Division of Neuro-oncology ... and new technology are impacting the development of new treatments and advancing strategies to ...
(Date:7/23/2015)... HONG KONG , July 23, 2015 ... ("HKSTP") has been given the prestigious accolade of ... magazine for its world-class position in fostering innovation ... Asia-Pacific region.  ... Economy, a UK-based innovation and technology magazine and ...
Breaking Biology Technology:3SBio Acquires Zhejiang Wansheng Pharmaceutical 23SBio Acquires Zhejiang Wansheng Pharmaceutical 33SBio Acquires Zhejiang Wansheng Pharmaceutical 4ImmunoCellular Therapeutics to Report Second Quarter 2015 Financial Results on August 6, 2015 2Experts Present How Science and New Technology are Driving New Brain Tumor Treatments and Improving Quality of Life 2Experts Present How Science and New Technology are Driving New Brain Tumor Treatments and Improving Quality of Life 3HKSTP Wins Most Innovative Technology Hub at The New Economy Awards 2015 2HKSTP Wins Most Innovative Technology Hub at The New Economy Awards 2015 3
... These Closely-Related Conditions Requires New Clinical Practices ... to Reduce Personal and Public Health Costs, ... International,Diabetes Federation (IDF) Task Force on Epidemiology and ... 2 diabetes and,obstructive sleep apnea (OSA) are closely ...
... DIEGO, June 6 Gen-Probe Incorporated,(Nasdaq: GPRO ) ... seventh,annual Needham & Company, LLC, Biotechnology and Medical Technology,Conference ... Eastern,Time (8 a.m. Pacific Time). The presentation is scheduled ... link on the investor information section,of Gen-Probe,s website at ...
... the internationally acclaimed surgeon presents the new state-of-the-art, research, technology and ... ... Raton., BOYNTON BEACH, ... Stewart G. Eidelson, officially,launched the new South Palm Orthospine Institute. Now ...
Cached Biology Technology:IDF Urges Healthcare Providers to Address the Relationship Between Type 2 Diabetes and Sleep Apnea 2IDF Urges Healthcare Providers to Address the Relationship Between Type 2 Diabetes and Sleep Apnea 3IDF Urges Healthcare Providers to Address the Relationship Between Type 2 Diabetes and Sleep Apnea 4Gen-Probe to Webcast Presentation at Seventh Annual Needham Biotechnology and Medical Technology Conference 2South Palm Orthospine Institute Now Open: World Renowned Orthopedic Specialist and Author, Stewart G. Eidelson, Announced the New Practice with a Focus on Spine and Spinal Stenosis 2
(Date:7/20/2015)... 20, 2015  Acuity Market Intelligence,s latest research ... of Commerce and Privacy" forecasts that between 2014 ... will be downloaded to smart mobile devices by ... market is projected to generate more than $67.9 ... seven-year forecast period.    "Biometrics is ...
(Date:7/13/2015)... , Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... provisional patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION ... new convenient and secure method to make payments.  ... payment methods, introduced with its groundbreaking voice-direct payment ...
(Date:7/9/2015)... Research and Markets( ... "Biometrics for Banking; Market & Technology Analysis, ... their offering. The adoption for banking ... and the forecast is that by 2020 it ... involved in delivering biometric systems to the banking ...
Breaking Biology News(10 mins):Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... as the lungs of the planet, inhales carbon dioxide as ... to grow parts that eventually fall to the ground to ... Until recently people believed much of the rain ... deep in the ocean. University of Washington research showed a ...
... novel vaccine study from South Dakota State University (SDSU) will ... American Association of Pharmaceutical Scientists, (AAPS) National Biotechnology Conference (NBC). ... 22 at the Sheraton San Diego Hotel and Marina. ... the immune system to fight against a pathogen that causes ...
... women of European descent inherit common foot disorders, such as ... claw toe. Findings from the Framingham Foot Studythe first to ... Arthritis Care & Research , a journal published by Wiley ... Previous studies show that as many as 60% of ...
Cached Biology News:Amazon River exhales virtually all carbon taken up by rain forest 2Amazon River exhales virtually all carbon taken up by rain forest 3Germ-fighting vaccine system makes great strides in delivery 2Blame your parents for bunion woes 2
Rabbit polyclonal to Syntrophin alpha 1 ( Abpromise for all tested applications). entrezGeneID: 6640 SwissProtID: Q13424...
Mouse monoclonal [4i97] to HLA Class 1 A25 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 1 Antigen-A25. Swiss Protein ID: P18462...
Mouse Anti-Human MCAF-(MCP-1)...
LTBP-1 (E-20)...
Biology Products: